USPIO-loaded red blood cells as a biomimetic MR contrast agent: A relaxometric study

Contrast Media and Molecular Imaging

Volumn 9, Issue 3, 2014, Pages 229-236

  Boni, Adriano ^a   Ceratti, Davide ^b   Antonelli, Antonella ^c   Sfara, Carla ^c   Magnani, Mauro ^c   Manuali, Elisabetta ^d   Salamida, Sonia ^d   Gozzi, Alessandro ^a   Bifone, Angelo ^a  

^a CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

^d ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL UMBRIA E DELLE MARCHE   (Italy)

Author keywords

Internalization; Iron oxide nanoparticles; Red blood cells; Relaxivity

Indexed keywords

HEMOGLOBIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OXYHEMOGLOBIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; DEXTRAN; FERUMOXTRAN-10; MAGNETITE NANOPARTICLE;

ARTICLE; BIOMIMETICS; CELL LEVEL; CONTROLLED STUDY; ENCAPSULATION; ERYTHROCYTE; HEMATOCRIT; HUMAN; HUMAN CELL; INTERNALIZATION; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PLASMA HALF LIFE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; CELL TRACKING; CHEMISTRY; DIAGNOSTIC USE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

BIOMIMETICS; CELL TRACKING; CONTRAST MEDIA; DEXTRANS; ERYTHROCYTES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES;

EID: 84897464826     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1562     Document Type: Article

References (32)

1. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11(11): 2319-2331; doi: 10.3978/j.issn.2223-4292.2011.08.03
2. Morana G, Salviato E, Guarise A. Contrast agents for hepatic MRI. Cancer Imag 2007; 7 Spec No A: S24-27; doi: 10.1102/1470-7330.2007.9001
3. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003; 13(6): 1266-1276; doi: 10.1007/s00330-002-1721-7
4. Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Acad Radiol 2005; 12(9): 1190-1197; doi: 10.1016/j.acra.2005.05.014
5. Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008; 60(11): 1252-1265; doi: 10.1016/j.addr.2008.03.018
6. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D: Appl Phys 2003; 36(13): R198-R206; doi: 10.1088/0022-3727/42/22/224003
7. Gindy ME, Prud'homme RK. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 2009; 6(8): 865-878; doi: 10.1517/17425240902932908
8. Antonelli A, Sfara C, Mosca L, Manuali E, Magnani M. New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles. J Nanosci Nanotechnol 2008; 8(5): 2270-2278; doi: 10.1166/jnn.2008.190
9. Antonelli A, Sfara C, Manuali E, Bruce IJ, Magnani M. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine 2011; 6(2): 211-223; doi: 10.2217/nnm.10.163
10. Gleich B, Weizenecker R. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005; 435(7046): 1214-1217; doi: 10.1038/Nature03808
11. Rahmer J, Weizenecker J, Gleich B, Borgert J. Analysis of a 3-D system function measured for magnetic particle imaging. IEEE Trans Med Imag 2012; 31(6): 1289-1299; doi: 10.1109/TMI.2012.2188639
12. Markov DE, Boeve H, Gleich B, Borgert J, Antonelli A, Sfara C, Magnani M. Human erythrocytes as nanoparticle carriers for magnetic particle imaging. Phys Med Biol 2010; 55(21): 6461-6473; doi: 10.1088/0031-9155/55/21/008
13. Antonelli A, Sfara C, Magnani M, Rahmer J, Gleich B, Borgert J, Weizenecker J. Red blood cells as magnetic carriers for MPI applications. In Magnetic Particle Imaging, Buzug TM, Borgert J (eds). Springer Proceedings in Physics, Vol. 140. Springer: Berlin, 2012; 175-179.
14. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003; 49(4): 646-654; doi: 10.1002/mrm.10418
15. Anzai Y, Prince MR, Chenevert TL, Maki JH, Londy F, London M, McLachlan SJ. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imag 1997; 7(1): 209-214.
16. Caravan P, Cloutier NJ, Greenfield MT, McDermid SA, Dunham SU, Bulte JW, Amedio JC, Jr., Looby RJ, Supkowski RM, Horrocks WD, Jr., McMurry TJ, Lauffer RB. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002; 124(12): 3152-3162; doi: 10.1021/ja017168k
17. Fink C, Goyen M, Lotz J. Magnetic resonance angiography with blood-pool contrast agents: future applications. Eur Radiol 2007; 17(suppl 2): B38-44.
18. Rapp JH, Wolff SD, Quinn SF, Soto JA, Meranze SG, Muluk S, Blebea J, Johnson SP, Rofsky NM, Duerinckx A, Foster GS, Kent KC, Moneta G, Middlebrook MR, Narra VR, Toombs BD, Pollak J, Yucel EK, Shamsi K, Weisskoff RM. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography - multicenter comparative phase III study. Radiology 2005; 236(1): 71-78; doi: 10.1148/radiol.2361040148
19. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998; 207(2): 529-538.
20. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32(12): 741-747.
21. Vogl TJ, Hammerstingl R, Schwarz W, Kummel S, Muller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996; 31(11): 696-708.
22. Weishaupt D, Hetzer FH, Ruehm SG, Patak MA, Schmidt M, Debatin JF. Three-dimensional contrast-enhanced MRI using an intravascular contrast agent for detection of traumatic intra-abdominal hemorrhage and abdominal parenchymal injuries: an experimental study. Eur Radiol 2000; 10(12): 1958-1964.
23. Reimer P, Schuierer G, Balzer T, Peters PE. Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume. Magn Reson Med 1995; 34(5): 694-697; doi: 10.1002/mrm.1910340507/pdf
24. Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 1999; 110(11): 5403-5411; doi: 10.1063/1.478435
25. Sigovan M, Boussel L, Sulaiman A, Sappey-Marinier D, Alsaid H, Desbleds-Mansard C, Ibarrola D, Gamondes D, Corot C, Lancelot E, Raynaud JS, Vives V, Lacledere C, Violas X, Douek PC, Canet-Soulas E. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 2009; 252(2): 401-409; doi: 10.1148/radiol.2522081484
26. Lartigue L, Wilhelm C, Servais J, Factor C, Dencausse A, Bacri JC, Luciani N, Gazeau F. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano 2012; 6(3): 2665-2678; doi: 10.1021/nn300060u
27. Levy M, Wilhelm C, Devaud M, Levitz P, Gazeau F. How cellular processing of superparamagnetic nanoparticles affects their magnetic behavior and NMR relaxivity. Contrast Media Mol Imag 2012; 7(4): 373-383; doi: 10.1002/cmmi.504
28. Maes RM, Lewin JS, Duerk JL, Misselwitz B, Kiewiet CJ, Wacker FK. A new type of susceptibility-artefact-based magnetic resonance angiography: intra-arterial injection of superparamagnetic iron oxide particles (SPIO) A Resovist in combination with TrueFisp imaging: a feasibility study. Contrast Media Mol Imag 2006; 1(5): 189-195; doi: 10.1002/cmmi.105
29. Mornet S, Vasseur S, Grasset F, Veverka P, Goglio G, Demourgues A, Portier J, Pollert E, Duguet E. Magnetic nanoparticle design for medical applications. Prog Solid State Chem 2006; 34(2-4): 237-247; doi: 10.1016/j.progsolidstchem.2005.11.010
30. Sigovan M. Superparamagnetic iron oxide based nanoparticles in atherosclerosis detection and characterization by highresolution magnetic resonance imaging. PhD dissertation, publication no. 264, Université de Lyon, 2009.
31. Ouakssim A, Roch A, Pierart C, Muller RN. Characterization of polydisperse superparamagnetic particles by nuclear magnetic relaxation dispersion (NMRD) profiles. J Magn Magn Mater 2002; 252(0): 49-52; doi: 10.1016/S0304-8853(02)00686-8
32. Bertini ILC (ed.). NMR of Paramagnetic Molecules in Biological System. Benjamin-Cummings: San Francisco, CA, 1986.